ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ARA American Renal Associates Holdings Inc

11.52
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
American Renal Associates Holdings Inc NYSE:ARA NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.52 0 01:00:00

AMERICAN RENAL NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In...

09/01/2017 9:42pm

PR Newswire (US)


American Renal Associates (NYSE:ARA)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more American Renal Associates Charts.

NEW YORK, Jan. 9, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at American Renal Associates Holdings, Inc. ("American Renal" or the "Company") (NYSE:ARA).

Faruqi & Faruqi, LLP

The investigation focuses on whether the Company and its executives violated federal securities laws by engaging in potentially fraudulent billing practices in order to boost profits.

Specifically, on January 3, 2017, the Company received a subpoena from U.S. Department of Justice, dated December 30, 2016, requesting information relating to: (1) topics related to applicable healthcare laws for period from January 1, 2013 through the present; (2) the Company's interactions with the American Kidney Fund.  The American Kidney Fund has come under accusations of steering patients away from Medicare and Medicaid programs into higher paying Affordable Care Act programs.

Request more information now by clicking here:  www.faruqilaw.com/ARA. There is no cost or obligation to you.

Take Action

If you invested in American Renal stock or options and would like to discuss your legal rights, visit www.faruqilaw.com/ARA.  You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding American Renal's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/american-renal-notification-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-in-excess-of-100000-investing-in-american-renal-associates-holdings-inc-to-contact-the-firm-300388111.html

SOURCE Faruqi & Faruqi, LLP

Copyright 2017 PR Newswire

1 Year American Renal Associates Chart

1 Year American Renal Associates Chart

1 Month American Renal Associates Chart

1 Month American Renal Associates Chart

Your Recent History

Delayed Upgrade Clock